$MGX News

Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Wells Fargo Maintains Overweight on Metagenomi Therapeutics, Lowers Price Target to $7

Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Metagenomi Q2 EPS $(0.73) Misses $(0.57) Estimate, Sales $(257.000K) Miss $2.960M Estimate

Chardan Capital Maintains Buy on Metagenomi Therapeutics, Lowers Price Target to $5

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Just Reported And Analysts Have Been Cutting Their Estimates

Wells Fargo Maintains Overweight on Metagenomi Therapeutics, Lowers Price Target to $9

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Metagenomi Q1 EPS $(0.61) Misses $(0.55) Estimate, Sales $1.248M Miss $5.925M Estimate

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

Metagenomi Reports Study Showing CRISPR Editing Efficiency; Findings Support Development of Deliverable Gene Editing Systems

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Metagenomi Therapeutics: Q4 Earnings Snapshot

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

Metagenomi Therapeutics Q4 Earnings Assessment

Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate

Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate

Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript